In a nutshell This study compared the frequency of allergic reactions to different doses of three biological therapies in patients with advanced melanoma. The authors found that different doses of the three drugs reduced the number of allergic reactions. Some background Biological therapy has significantly improved treatment results for patients...
Read More
In a nutshell This article reviewed treatment options for patients with advanced melanoma. Some background Treatment for melanoma depends on several factors, including the disease stage. Advanced melanoma is diagnosed when cancer can be detected outside of the original tumor. This makes treatment difficult. Currently, there...
Read More
In a nutshell This study investigated the effectiveness of Talimogene Laherparepvec (T-VEC) combined with ipilimumab (Yervoy) and ipilimumab alone to treat patients with melanoma. Researchers suggested that the combined treatment was associated with better outcomes. Some background Newer therapies, such as immunotherapy have changed cancer...
Read More
In a nutshell This study examined the most accurate predictor of survival in patients with metastatic melanoma being treated with bevacizumab (Avastin). Some background Since melanomas are highly dependent on the formation of new blood vessels, bevacizumab (Avastin), a drug which blocks new blood vessel formation, is often used in their treatment....
Read More
